Vital KSK HoldingsTSE:3151 +0.46%68 Net Margin % is 1.01% as of Mar. 2026, which is 22% above its 10-year median of 0.83. GuruFocus rates TSE:3151 with a GF Score™ of 68/100 and a GF Value™ of 円1,322.50 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 119 Medical Distribution companies, Vital KSK Holdings ranks worse than 59.66% on this metric.
The historical rank and industry rank for Vital KSK Holdings's Net Margin % or its related term are showing as below:
TSE:3151'
s Net Margin % Range Over the Past 10 Years
Min: 0.22 Med: 0.83 Max: 1.22
Current: 1.21
TSE:3151's Net Margin % is ranked worse than 59.66% of 119
companies
in the Medical Distribution industry
Industry Median: 1.53
vs TSE:3151: 1.21
Vital KSK Holdings (TSE:3151) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Vital KSK Holdings Net Margin % Related Terms
Vital KSK Holdings Net Margin % Historical Data
* Premium members only.
The historical data trend for Vital KSK Holdings's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:3151 vs MCK, COR, CAH: Net Margin % Comparison
For the Medical Distribution subindustry, Vital KSK Holdings's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vital KSK Holdings Net Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Vital KSK Holdings's Net Margin % distribution charts can be found below:
* The bar in red indicates where Vital KSK Holdings's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vital KSK Holdings (TSE:3151) has a Net Margin % of 1.01% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Vital KSK Holdings and its competitors. This is 22% above median its historical median of 0.83. Over the past decade, Vital KSK Holdings' Net Margin % has ranged from 0.22 to 1.22. According to the industry distribution chart, Vital KSK Holdings ranks #71 out of 119 companies in the Medical Distribution industry, placing it in the top 59.7%.
Is Vital KSK Holdings' Net Margin % too high?
Vital KSK Holdings' current Net Margin % of 1.01% is 22% above median its 10-year median of 0.83. Over the past 10 years, this metric has ranged from a low of 0.22 to a high of 1.22. The Medical Distribution industry median Net Margin % is 1.53. Vital KSK Holdings' value of 1.01% is 34% below this industry median. Based on the distribution chart, Vital KSK Holdings ranks #71 out of 119 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Vital KSK Holdings has a GF Score™ of 68/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vital KSK Holdings' Net Margin % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Vital KSK Holdings ranks #71 out of 119 companies for Net Margin %. This places Vital KSK Holdings in the lower half of its industry. The industry median Net Margin % is 1.53. Vital KSK Holdings' value of 1.01% is 34% below this benchmark. Historically, Vital KSK Holdings' own Net Margin % has ranged from 0.22 to 1.22 over the past decade. While the company's 10-year median is 0.83 vs. the industry median of 1.53, Vital KSK Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Distribution company?
The median Net Margin % among Medical Distribution companies is 1.53, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vital KSK Holdings's current Net Margin % of 1.01% is 34% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Vital KSK Holdings and its competitors. For the Medical Distribution industry, the median Net Margin % is 1.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vital KSK Holdings's current Net Margin % is 1.01%, which is 22% above median its own 10-year median of 0.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vital KSK Holdings stock overvalued right now?
Based on GuruFocus' analysis, Vital KSK Holdings (TSE:3151) is currently considered Modestly Overvalued. The stock's GF Value™ is 円1,322.50, compared to a current price of 円1,532.00 — trading 15.8% above its estimated fair value. The current Net Margin % is 1.01%, which is 22% above median its 10-year median of 0.83 and 34% below the Medical Distribution industry median of 1.53. Vital KSK Holdings' overall GF Score™ is 68/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Vital KSK Holdings (TSE:3151), the current Net Margin % is 1.01% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vital KSK Holdings (TSE:3151) Overvalued in 2026?
Based on GuruFocus' analysis, Vital KSK Holdings stock appears to be overvalued.
The current stock price of 円1,532.00 is trading 15.8% above its estimated GF Value™ of 円1,322.50.
GuruFocus considers Vital KSK Holdings to be Modestly Overvalued.
Key valuation signals for TSE:3151:
Net Margin %: 1.01% (22% above median its 10-year median of 0.83)
GF Value™: 円1,322.50 vs. price of 円1,532.00 (15.8% above fair value)
Industry Position: 34% below the Medical Distribution median (#71 of 119)
No single metric tells the full story. See the TSE:3151 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vital KSK Holdings Inc engaged in the wholesale and retail of pharmaceutical products. It operates through the Pharmaceutical Wholesale and Other segments. The Pharmaceutical Wholesale segment sells medicines, diagnostics, and medical devices to hospitals, medical institutions, and health practitioners. The Other segment includes retail of pharmaceutical products, wholesale of agrochemical and veterinary drugs, transportation, nursing care services, and medical consultancies. All the business activity of the group is primarily functioned through Japan and distributes its product within the Korean and to overseas market.
68GF Score
Get the complete analysis for TSE:3151
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3151 has been successfully added to your 
